Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diovan in acute ischemic stroke
NCT00874601Phase 4
Key facts
- Status
- Unknown
- Start
- Oct 2008
- Primary completion
- Jul 2011
- Countries
- 1
- Sponsor
- Hallym University Medical Center
- Modality
- Small Molecules
- Drugs
- valsartan
- Conditions
- ischemic stroke
01
Overview
Phase 4, randomised, single-blind trial of valsartan in ischemic stroke, sponsored by Hallym University Medical Center. Primary endpoint: Modified Rankin Scale at 90 days. Status: unknown.
02
Design
- Study design
- RandomizedSingle-blind
03
Who it enrols
Adults with acute ischemic stroke within 48 hours of onset, SBP between 150-185 mmHg, NIHSS 2-21, and premorbid mRS 0-1.
04
Endpoints
Primary
Modified Rankin Scale
Beyond the preview
Go deeper on NCT00874601.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874601.